Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy
2015 ◽
Vol 19
(11)
◽
pp. 1143-1156
◽
2013 ◽
Vol 71
(Suppl 3)
◽
pp. 368.3-369
2015 ◽
Vol 74
(Suppl 2)
◽
pp. 1071-1071
◽
2014 ◽
Vol 73
(Suppl 2)
◽
pp. 939.1-939
2013 ◽
Vol 72
(Suppl 3)
◽
pp. A238.2-A238
2015 ◽
Vol 34
(9)
◽
pp. 1513-1519
◽
2016 ◽
Vol 75
(Suppl 2)
◽
pp. 412.2-413
◽
2017 ◽
2013 ◽
Vol 24
(4)
◽
pp. 552-560
◽